RETO (RETO) Stock Price & Analysis
RETO (RETO) fell 2.28% to USD 2.74 as of July 25, 2026 at 06:10 UTC, according to Nexqual real-time market data.
RETO last closed at USD 2.8; the session ranged USD 2.5–2.74 on volume of 4,081 shares. Market capitalization is $23.21M, with a 52-week range of USD 1.8–57 (NCM). Source: Nexqual, July 25, 2026 at 06:10 UTC.
Key Statistics (as of July 25, 2026 at 06:10 UTC)
| Price | USD 2.74 |
|---|---|
| Change | ▼ 2.28% (down) |
| Previous Close | USD 2.8 |
| Open | USD 2.53 |
| Day Range | USD 2.5 – 2.74 |
| 52-Week Range | USD 1.8 – 57 |
| Volume | 4,081 shares |
| Market Cap | $23.21M |
| Exchange | NCM |
Technical Analysis (RETO)
Nexqual's technical model rates RETO "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 06:10 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.53 (neutral) |
| vs SMA50 | Above (USD 2.59) |
| MACD | 0.07 (positive) |
Analyst Ratings (RETO)
Wall Street analysts rate RETO "None", per Nexqual as of July 25, 2026 at 06:10 UTC.
| Consensus Rating | None |
|---|
Earnings (RETO)
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financials & Fundamentals (RETO)
| Total Revenue | $3.37M |
|---|---|
| Revenue Growth (YoY) | +118.90% |
| Gross Margin | +35.29% |
| Operating Margin | -67.44% |
| Profit Margin | +0.00% |
| ROE | -46.15% |
| Debt / Equity | 9.85 |
| Current Ratio | 0.21 |
| Total Cash | $250,008 |
| Total Debt | $2.44M |
| Free Cash Flow | $-2.73M |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financial Health Score (RETO)
Nexqual rates RETO's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:10 UTC.
| Growth | Strong — Revenue +119% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $250K cash vs $2M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -46%, ROA -5.6% |
Ownership (RETO)
| Insider Ownership | +0.90% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 8.22M |
| Float | 3.26M |
| Short % of Float | +0.17% |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Leadership (RETO)
RETO is led by Sie Wei Tiong (age 37), CEO & Director, per Nexqual as of July 25, 2026 at 06:10 UTC.
| CEO & Director | Sie Wei Tiong (age 37) |
|---|---|
| President, COO & Director | Xinyang Li (age 30) |
| Chief Financial Officer | Yue Hu (age 36) |
| Chief Technology Officer | Zhizhong Hu (age 62) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SXTC | China SXT Pharmaceuticals, Inc. | USD 0.06 | ▼ 96.84% |
| PETZ | TDH Holdings, Inc. | USD 1.18 | ▼ 1.67% |
| AIHS | Senmiao Technology Limited | USD 1.33 | ▼ 6.34% |
| TAOP | Taoping Inc. | USD 0.82 | ▼ 33.06% |
| DOGZ | Dogness (International) Corpora | USD 0.94 | ▼ 6.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:10 UTC. This page is informational and not investment advice.